Management projects "revenue growth of at least 8% over 2025 with Q1 2026 revenue of approximately $18.5 million." Koblish explained the guidance: "Given the change that we've implemented -- wholesale ...
The next one may be something many executives still treat as niche: biology made usable through digital systems. A profound ...
William Blair has initiated coverage on coverage of Bio-Techne Corp TECH with an Outperform rating. Bio-Techne is positioned in high-growth and attractive end-markets, notably cell and gene therapy (C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results